129 related articles for article (PubMed ID: 38334957)
1. Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors.
Heuser A; Abdul Rahman W; Bechter E; Blank J; Buhr S; Erdmann D; Fontana P; Mermet-Meillon F; Meyerhofer M; Strang R; Schrapp M; Zimmermann C; Cortes-Cros M; Möbitz H; Hamon J
ChemMedChem; 2024 Apr; 19(8):e202300613. PubMed ID: 38334957
[TBL] [Abstract][Full Text] [Related]
2. Identification of 2-Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay.
Parker MJ; Lee H; Yao S; Irwin S; Hwang S; Belanger K; de Mare SW; Surgenor R; Yan L; Gee P; Morla S; Puyang X; Hsiao P; Zeng H; Zhu P; Korpal M; Dransfield P; Bolduc DM; Larsen NA
Biochemistry; 2023 Jul; 62(14):2147-2160. PubMed ID: 37403936
[TBL] [Abstract][Full Text] [Related]
3. Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.
Ferretti S; Hamon J; de Kanter R; Scheufler C; Andraos-Rey R; Barbe S; Bechter E; Blank J; Bordas V; Dammassa E; Decker A; Di Nanni N; Dourdoigne M; Gavioli E; Hattenberger M; Heuser A; Hemmerlin C; Hinrichs J; Kerr G; Laborde L; Jaco I; Núñez EJ; Martus HJ; Quadt C; Reschke M; Romanet V; Schaeffer F; Schoepfer J; Schrapp M; Strang R; Voshol H; Wartmann M; Welly S; Zécri F; Hofmann F; Möbitz H; Cortés-Cros M
Nature; 2024 May; 629(8011):443-449. PubMed ID: 38658754
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).
Sommers JA; Kulikowicz T; Croteau DL; Dexheimer T; Dorjsuren D; Jadhav A; Maloney DJ; Simeonov A; Bohr VA; Brosh RM
PLoS One; 2019; 14(1):e0210525. PubMed ID: 30625228
[TBL] [Abstract][Full Text] [Related]
5. Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability.
Yang H; Kang M; Jang S; Baek SY; Kim J; Kim GU; Kim D; Ha J; Kim JS; Jung C; Kim NJ; Cho SY; Shin WH; Lee J; Ko J; Lee A; Keum G; Lee S; Kang T
Bioorg Med Chem; 2024 Feb; 100():117588. PubMed ID: 38295487
[TBL] [Abstract][Full Text] [Related]
6. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair.
Chen L; Huang S; Lee L; Davalos A; Schiestl RH; Campisi J; Oshima J
Aging Cell; 2003 Aug; 2(4):191-9. PubMed ID: 12934712
[TBL] [Abstract][Full Text] [Related]
7. Competition between the DNA unwinding and strand pairing activities of the Werner and Bloom syndrome proteins.
Machwe A; Lozada EM; Xiao L; Orren DK
BMC Mol Biol; 2006 Jan; 7():1. PubMed ID: 16412221
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR.
Zong D; Koussa NC; Cornwell JA; Pankajam AV; Kruhlak MJ; Wong N; Chari R; Cappell SD; Nussenzweig A
Genes Dev; 2023 Oct; 37(19-20):913-928. PubMed ID: 37932011
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic mechanism of the WRN helicase/nuclease.
Brosh RM; Opresko PL; Bohr VA
Methods Enzymol; 2006; 409():52-85. PubMed ID: 16793395
[TBL] [Abstract][Full Text] [Related]
10. WRN Is a Promising Synthetic Lethal Target for Cancers with Microsatellite Instability (MSI).
Chan EM; Foster KJ; Bass AJ
Cancer Treat Res; 2023; 186():313-328. PubMed ID: 37978143
[TBL] [Abstract][Full Text] [Related]
11. Coordinate action of the helicase and 3' to 5' exonuclease of Werner syndrome protein.
Opresko PL; Laine JP; Brosh RM; Seidman MM; Bohr VA
J Biol Chem; 2001 Nov; 276(48):44677-87. PubMed ID: 11572872
[TBL] [Abstract][Full Text] [Related]
12. Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.
Baltgalvis KA; Lamb KN; Symons KT; Wu CC; Hoffman MA; Snead AN; Song X; Glaza T; Kikuchi S; Green JC; Rogness DC; Lam B; Rodriguez-Aguirre ME; Woody DR; Eissler CL; Rodiles S; Negron SM; Bernard SM; Tran E; Pollock J; Tabatabaei A; Contreras V; Williams HN; Pastuszka MK; Sigler JJ; Pettazzoni P; Rudolph MG; Classen M; Brugger D; Claiborne C; Plancher JM; Cuartas I; Seoane J; Burgess LE; Abraham RT; Weinstein DS; Simon GM; Patricelli MP; Kinsella TM
Nature; 2024 May; 629(8011):435-442. PubMed ID: 38658751
[TBL] [Abstract][Full Text] [Related]
13. Werner syndrome protein. I. DNA helicase and dna exonuclease reside on the same polypeptide.
Shen JC; Gray MD; Oshima J; Kamath-Loeb AS; Fry M; Loeb LA
J Biol Chem; 1998 Dec; 273(51):34139-44. PubMed ID: 9852073
[TBL] [Abstract][Full Text] [Related]
14. Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer.
Hao S; Tong J; Jha A; Risnik D; Lizardo D; Lu X; Goel A; Opresko PL; Yu J; Zhang L
Proc Natl Acad Sci U S A; 2022 Dec; 119(51):e2211775119. PubMed ID: 36508676
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and kinetic characterization of the DNA helicase and exonuclease activities of werner syndrome protein.
Choudhary S; Sommers JA; Brosh RM
J Biol Chem; 2004 Aug; 279(33):34603-13. PubMed ID: 15187093
[TBL] [Abstract][Full Text] [Related]
16. p53 modulates RPA-dependent and RPA-independent WRN helicase activity.
Sommers JA; Sharma S; Doherty KM; Karmakar P; Yang Q; Kenny MK; Harris CC; Brosh RM
Cancer Res; 2005 Feb; 65(4):1223-33. PubMed ID: 15735006
[TBL] [Abstract][Full Text] [Related]
17. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase.
Yannone SM; Roy S; Chan DW; Murphy MB; Huang S; Campisi J; Chen DJ
J Biol Chem; 2001 Oct; 276(41):38242-8. PubMed ID: 11477099
[TBL] [Abstract][Full Text] [Related]
18. WRN helicase is a synthetic lethal target in microsatellite unstable cancers.
Chan EM; Shibue T; McFarland JM; Gaeta B; Ghandi M; Dumont N; Gonzalez A; McPartlan JS; Li T; Zhang Y; Bin Liu J; Lazaro JB; Gu P; Piett CG; Apffel A; Ali SO; Deasy R; Keskula P; Ng RWS; Roberts EA; Reznichenko E; Leung L; Alimova M; Schenone M; Islam M; Maruvka YE; Liu Y; Roper J; Raghavan S; Giannakis M; Tseng YY; Nagel ZD; D'Andrea A; Root DE; Boehm JS; Getz G; Chang S; Golub TR; Tsherniak A; Vazquez F; Bass AJ
Nature; 2019 Apr; 568(7753):551-556. PubMed ID: 30971823
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Werner syndrome helicase activity by benzo[a]pyrene diol epoxide adducts can be overcome by replication protein A.
Choudhary S; Doherty KM; Handy CJ; Sayer JM; Yagi H; Jerina DM; Brosh RM
J Biol Chem; 2006 Mar; 281(9):6000-9. PubMed ID: 16380375
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal domain of the large subunit of human replication protein A binds to Werner syndrome protein and stimulates helicase activity.
Shen JC; Lao Y; Kamath-Loeb A; Wold MS; Loeb LA
Mech Ageing Dev; 2003; 124(8-9):921-30. PubMed ID: 14499497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
